| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of BioStem Technologies (NASDAQ:BSEM) through any online brokerage.
Other companies in BioStem Technologies’s space includes: Eli Lilly and Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), Merck & Co Inc (NYSE:MRK), Novartis AG (NYSE:NVS) and AstraZeneca PLC (NYSE:AZN).
There is no analysis for BioStem Technologies to provide a consensus price target.
The stock price for BioStem Technologies (NASDAQ: BSEM) is $2.7399 last updated October 2, 2026 at 7:30 PM EDT.
There are no upcoming dividends for BioStem Technologies.
BioStem Technologies does not have any upcoming earnings scheduled.
There is no upcoming split for BioStem Technologies.
BioStem Technologies is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
BioStem Technologies Inc is a regenerative biotechnology company focused on harnessing elements of perinatal tissue and the body's innate biology to repair or reverse damage caused by a broad range of degenerative diseases. The company develops,...